Response from the MS Society

[Guest guest]

Below is my response from the MS Society. I get the impression that they

would study this if they had a serious study proprosal for funding from an

investigator. They only write the checks, they don't actually conduct their

own studies. I'll forward my letter and its response to Dr. Bihari.

Perhaps he or one of his colleagues could send them a proprosal and be

willing to set up a study.

- Ben

Dear Dr. ,

Thank you for contacting the Professional Resource Center of the National MS

Society. As you know there are no published data relating to low-dose

naltrexone and MS. Dr. Bihari's website provides a general overview, with

sections on lots of diseases. The section on MS states quite clearly that

the

claims are anecdotal and can't be considered sound or convincing in the

absence

of clinical trials. The National MS Society would be willing to consider

support of any bona fide, high quality proposal to test this substance in

MS, as

we are open to any study of any sort related to MS. It would, as are all

proposals, be subject to scrutiny and peer review. To date, the Society has

never been approached by Dr. Bihari or any other investigator to consider

such a

study.

In the meantime, we do not recommend the use of low-dose naltrexone to

people

with MS. Dr. Bihari's website promotes its immune system-enhancing

properties,

and, in the absence of sound evidence to the contrary, the medical consensus

is

that the immune system in people with MS is already overactive and in no

need of

a further boost. If you have additonal questions, please don't hesitate to

get

back to us.

Let me know if you would like to be added to our email list to receive

periodic

research and clinical updates.

_________________________________________________________________

Persistent heartburn? Check out Digestive Health & Wellness for information

and advice. http://gerd.msn.com/default.asp